Skip to main content

Part of the book series: Methods in Clinical Pharmacology ((MECLPH))

  • 23 Accesses

Summary

Labetalol is an effective antihypertensive agent that has a good record of safety, as indicated by the Adverse Reation Data Base collated over the past seven years. The principal side effects are scalp tingling, acute retention of urine, postural hypotension, bronchospasm, and gastric disturbance. These did not occur with a higher incidence than those encountered with other antihypertensives, and were dose related.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brittain, R. T., and Levy, G. P. (1976). Br. J. Clin. Pharmacol. 3, 681–694.

    CAS  Google Scholar 

  2. Richards, D. A., and Prichard, B. N. C. (1979). European Society of Cardiology Symposium on Labetalol. Florence, pp. 16–19.

    Google Scholar 

  3. Michaelson, E. L. et al. (1983). Multicenter clinical evaluation of long term efficacy and safety of labetalol in the treatment of hypertension. American Journal of Medicine, Dallas Symposium Oct. 17th 1982, pp. 68–80.

    Google Scholar 

  4. Kane, J., Gregg, I., and Stephens, M. D. B., (1979). Long term study of labetalol in general practice. Br. J. Clin. Pharmacol. 8, Suppl. 2, 167.

    Google Scholar 

  5. McAreavey, D. et al. (1984). “Third Drug” Trial: comparative study of antihypertensive agents added to the treatment when BP remains uncontrolled by beta-blockers plus thiazide diuretic. B. M. J. 288, 106–110.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer Fachmedien Wiesbaden

About this chapter

Cite this chapter

Feldschreiber, P. (1984). The Clinical Profiles of Long Term Labetalol Therapy. In: Rietbrock, N., Woodcock, B.G. (eds) Balanced Alpha/Beta Blockade of Adrenoceptors / Balancierte Blockade von Alpha- und Beta-Adrenozeptoren. Methods in Clinical Pharmacology. Vieweg+Teubner Verlag, Wiesbaden. https://doi.org/10.1007/978-3-663-20205-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-663-20205-9_5

  • Publisher Name: Vieweg+Teubner Verlag, Wiesbaden

  • Print ISBN: 978-3-528-07922-2

  • Online ISBN: 978-3-663-20205-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics